General News Regulated Oxurion Announces Extraordinary and Annual Shareholders’ Meetings EN NL April 1, 2022
General News Regulated Oxurion succesfully raises EUR >10 MILLION from leading US and European healthcare investors in a private equity placement EN NL March 3, 2022
General News Regulated Oxurion NV announces 2021 Full Year Results and 2022 Outlook EN NL February 22, 2022
General News Oxurion Announces New Data on THR-149 Phase 2 Clinical Trial (“KALAHARI”) in DME at the Angiogenesis, Exudation, and Degeneration 2022 Conference EN February 14, 2022
General News Oxurion Announces Upcoming Presentation on THR-149 Phase 2 Clinical Trial (“KALAHARI”) at the Angiogenesis, Exudation, and Degeneration 2022 Conference EN February 11, 2022
General News OXURION to Participate in the 10th edition of Degroof Petercam’s Healthcare Conference EN January 18, 2022
General News OXURION to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference EN January 4, 2022
General News Regulated OXURION NV Secures EUR 10 Million Convertible Bond Financing from Kreos Capital and Pontifax Ventures EN November 22, 2021
General News First Patient Dosed in Part B of Phase 2 KALAHARI Study Evaluating Multiple Administrations of THR-149 versus aflibercept for Treatment of Diabetic Macular Edema (DME) EN November 15, 2021
General News Oxurion NV Announces Initiation of Equity Analyst Coverage by H.C. Wainwright with a “Buy” Recommendation EN November 4, 2021
General News Oxurion NV Announces First Patient Dosed in its Phase 2 Study Evaluating THR-687 for the treatment of Diabetic Macular Edema (DME) EN October 13, 2021
General News Positive Phase 2 Part A THR-149 data shared at the America Society of Retina Specialists (ASRS) Annual Scientific Meeting EN October 11, 2021
General News OXURION to Present at the Lytham Partners Fall 2021 Investor Conference EN October 5, 2021
General News Regulated OXURION Announces Positive Results from Part A of Phase 2 Study Evaluating THR-149 for Treatment of Diabetic Macular Edema (DME) EN September 30, 2021
